Prot #NU-AR-2015-01:Prospective, Placebo-Controlled, Double-blind, Randomized Intra-Individual Comparative Clinical study to Assess the Safety and the Efficacy of AR/101 Compared to Placebo when Administered Concomitantly with Standard of Care in Accelera